- Reported transaction lines
- 1
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Yates Clayton Clopton Director · 10% owner · Genvor Inc | GNVR Genvor Inc | Equity grant or awardFiling detailsSEC transaction code A Common Stock · Indirect ownership · ACT Holdings, LLC · Reported balance after transaction: 600000 · Shares issued upon Dr. Yates' conversion of $100,000 in outstanding payables owed by the Company to Dr. Yates, pursuant to his scientific advisor agreement with the Company and the Company's restructured compensation package previously approved by the Company, which permits Dr. Yates to convert amounts due to him into Company common stock. · Dr. Yates has voting and dispositive power with respect to shares held in the name of ACT Holdings, LLC, and is therefore deemed to be beneficial owner of shares held in its name. | 2026-04-15 | 2026-11-03 | 200,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.